首页
登录
职称英语
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
游客
2023-08-27
72
管理
问题
A personalized blood test that can identify tumor(肿瘤)DNA could be the first step towards a long-promised revolution in the way cancer is treated.
In the short term, the test—reported by Victor Velculescu of Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and his colleagues in Science Translational Medicine—could be used to spot cancer recurrence before tumor growth shows up on scans, meaning that treatment could be started earlier.
The test detects genetic rearrangements that distinguish cancer cells from normal cells. Eventually it might also pave the way for more personalized cancer treatments tailored to the genetic signature of individuals’ tumors.
Doctors already classify cancers by some of the genes that get switched on by the disease, and use this to guide treatment in some cases. For example, breast cancers are often divided into those that express oestrogen(雌激素)receptors on their surface and are therefore likely to respond to the drug tamoxifen(三苯氧胺), and those that don’t.
Genes have also been identified that predict whether a variety of cancers are resistant to radiotherapy and certain drugs, and might therefore need a different sort of treatment. It is also possible to stratify(使分层)cancers into aggressive and non-aggressive subtypes(类型)according to their genetic make-up.
But that’s just the beginning. In the future, pretty much all cancers are likely to be defined by the genetic pathways that drive their growth, rather than where in the body they manifest themselves. And because cancers mutate as they grow, it should be possible to track these changes and tailor patients’ therapies accordingly.
Velculescu’s test is a step towards this. The real breakthrough will come when such blood tests become sophisticated enough to reveal how tumors are changing over time, rather than simply spotting that they have come back. That should truly revolutionize cancer treatment, enabling the most effective combinations of drugs to be tailored to individual patients—and without the need for painful tissue biopsies(生检采样). [br] According to the passage, cancer cells and normal cells can be separated by the test due to its ability to find out______.
选项
答案
genetic rearrangement
解析
本题考查该检测手段的具体功能。定位句指出,该血液检测可发现基因重组,而这能够将癌细胞和正常细胞区分开。题干中的find out与原文中的detects意思相同,因此detects之后的宾语genetic rearrangement就是本题答案。
转载请注明原文地址:https://tihaiku.com/zcyy/2961543.html
相关试题推荐
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
随机试题
[originaltext]Thereisawidespreadassumptionthatworkgetsharderafter
Theboxer______hisopponentashardashecould.(1994年考试真题)A、punchedB、slapped
吉兰-巴雷综合征的病人低效型呼吸的主要原因是A.面神经麻痹 B.弛缓性瘫痪
A.陈皮 B.椿根皮 C.梨皮 D.地骨皮 E.丹皮泻白散含有
关于司型股权投资基金收益分配,下列说法错误的是()A.公司型股权投资基金收益分
1991-42.哮证发作期的病因病理关键是 A.宿痰内伏于肺B.外邪侵袭,
含有泡沫细胞的囊肿是A.皮样囊肿 B.表皮样囊肿 C.鳃裂囊肿 D.黏液囊
(2018年真题)关于国家所有的不可移动文物范围的说法,正确的是()。A.纪
关于材料消耗的性质及确定材料消耗量的基本方法,下列说法正的是()。A.理论计算
住宅室内装饰装修分户工程验收应提供的检测资料有()。A.内门窗气密性、水密性检
最新回复
(
0
)